Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : License symbols : Lly save search
Elektrofi and Lilly Enter Multi-Target Research Collaboration and License Agreement
Published: 2023-10-24 (Crawled : 12:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
license research collaboration agreement
HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China
Published: 2023-01-23 (Crawled : 10:00) - biospace.com/
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: -0.25%
H: 0.4%
C: -0.25%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: -1.27%
license china
TRexBio Announces Collaboration and License Agreement with Lilly to Develop and Commercialize Novel Therapies for Immune-Mediated Diseases
Published: 2023-01-09 (Crawled : 13:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
collaboration license agreement
Sosei Heptares and Lilly Enter Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases
Published: 2022-12-16 (Crawled : 01:00) - globenewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.58%
H: 0.71%
C: 0.54%
metabolic collaboration license diabetes agreement
Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Small Molecule Activators of AMPK
Published: 2022-10-11 (Crawled : 13:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -1.2%
H: 2.82%
C: 2.38%
research collaboration license therapeutics agreement
Aclaris Therapeutics Announces Patent License Agreement with Lilly for Alopecia Areata
Published: 2022-08-25 (Crawled : 12:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.54%
H: 0.86%
C: 0.79%
ACRS | $1.23 0.82% 0.81% 560K
|
Health Technology
|
| O: 1.27%
H: 3.94%
C: 3.94%
patent license therapeutics agreement
Better Together: New Licensing and Collaboration Deals to Watch
Published: 2022-04-11 (Crawled : 16:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.45%
H: 0.21%
C: -1.32%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -2.44%
H: 3.61%
C: 2.68%
collaboration license
Kyttaro Announces Worldwide Exclusive Licensing Agreement With Lilly for Antibody Therapeutic Program
Published: 2022-04-11 (Crawled : 13:20) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.45%
H: 0.21%
C: -1.32%
antibody program license
Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab
Published: 2022-04-10 (Crawled : 00:00) - prnewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.45%
H: 0.21%
C: -1.32%
license
ImmunoGen Announces a Global, Multi-Target License Agreement of its Novel Camptothecin ADC Platform to Lilly for Up to $1.7 Billion
Published: 2022-02-15 (Crawled : 13:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.84%
H: 3.44%
C: 3.04%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 2.53%
H: 5.43%
C: 2.11%
license platform
Dicerna Announces Two Targets Meet Preclinical Proof of Principle Criteria in Neurodegeneration and Pain Under Global Research Collaboration and Licensing Agreement With Lilly
Published: 2021-11-12 (Crawled : 14:00) - biospace.com/
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
ALNY | $145.23 -1.02% -1.03% 500K
|
Health Technology
|
| O: -2.06%
H: 0.0%
C: 0.0%
preclinical collaboration research license pre-clinical
Hemogenyx Pharmaceuticals Announces CDX Licence Agreement
Published: 2021-10-13 (Crawled : 10:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.55%
H: 1.64%
C: 1.01%
license
UNION therapeutics and Innovent Biologics enter into strategic collaboration and license agreement for orismilast, a next-generation PDE4 inhibitor for inflammatory dermatology conditions
Published: 2021-09-28 (Crawled : 07:00) - prnewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.0%
H: 0.0%
C: -2.12%
collaboration license
Innovent and UNION Therapeutics Enter into Strategic Collaboration and License Agreement for Orismilast, a Next-generation PDE4 Inhibitor for Inflammatory Dermatology Conditions
Published: 2021-09-28 (Crawled : 00:00) - prnewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.0%
H: 0.0%
C: -2.12%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: -0.27%
H: 0.81%
C: -0.56%
collaboration license
ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly
Published: 2021-09-08 (Crawled : 21:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.08%
H: 0.44%
C: 0.09%
PRQR | $1.92 -4.0% -4.17% 200K
|
Health Technology
|
| O: 0.0%
H: 0.29%
C: -2.16%
collaboration research license
Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor)
Published: 2021-09-02 (Crawled : 00:00) - prnewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.0%
H: 0.9%
C: 0.84%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: 0.23%
H: 0.65%
C: 0.03%
license
Synaffix Licenses its Award-Winning ADC Technology in Deal Adding a New ADC to Innovent’s Pipeline
Published: 2021-06-29 (Crawled : 13:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.01%
H: 1.38%
C: 0.49%
license technology
Innovent Announces License Agreement with Synaffix in an ADC Technology Deal
Published: 2021-06-29 (Crawled : 00:00) - prnewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.01%
H: 1.38%
C: 0.49%
license technology
AnHeart Therapeutics and Innovent Biologics Announce Exclusive License Agreement for Taletrectinib in Greater China
Published: 2021-06-01 (Crawled : 09:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.29%
H: 0.28%
C: -0.95%
heart china license
Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China
Published: 2021-06-01 (Crawled : 01:00) - prnewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.29%
H: 0.28%
C: -0.95%
heart china license
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.